Join our
Investor Newsletter

To receive Investor News as it is released please sign up

News Releases

Renalytix Launches myIntelX

March 9, 2022
RNS Number : 1092E Renalytix PLC 09 March 2022   Renalytix plc ("Renalytix" or the "Company")   Renalytix Launches myIntelX, Providing National Physician Access to KidneyIntelX Testing Platform   myIntelX will be launching in conjunction with KidneyIntelX going live at Atrium Health , and will

Presentation of new clinical data for KidneyIntelX

February 24, 2022
RNS Number : 6330C Renalytix PLC 24 February 2022     KidneyIntelX TM Clinical Results Presented at World Congress of Nephrology Demonstrate Improved Prediction of Kidney Function Over Standard of Care   Data highlights strength of KidneyIntelX for clinical use in early-stage diabetic kidney

RENX to Present at Cowen 42nd Annual Conference

February 22, 2022
RNS Number : 3488C Renalytix PLC 22 February 2022       Renalytix plc ("Renalytix" or the "Company")   Renalytix to Present at Cowen 42 nd Annual Health Care Conference   New York and SALT LAKE CITY , February 22, 2022 -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) ("Renalytix" or the "Company") today

Timothy Scannell to be appointed to board

February 22, 2022
RNS Number : 3394C Renalytix PLC 22 February 2022     Renalytix plc ("Renalytix" or the "Company")   Renalytix to Appoint Timothy Scannell to Board of Directors NEW YORK, NY and SALT LAKE CITY, UT   February 22, 2022 - Renalytix plc   (NASDAQ: RNLX) (LSE: RENX) today announced its intention to

Grant of Share Options

January 27, 2022
RNS Number : 8956Z Renalytix PLC 27 January 2022       Renalytix plc ("Renalytix" or the "Company")   Grant of Share Options   New York and SALT LAKE CITY , January 27, 2022 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that its Remuneration Committee has agreed to issue options over a total

Conference attendance

January 27, 2022
RNS Number : 7789Z Renalytix PLC 27 January 2022       Renalytix plc ("Renalytix" or the "Company")   Renalytix to Present at BTIG MedTech, Digital Health , Life Science & Diagnostic Tools Conference   New York and SALT LAKE CITY , January 27, 2022 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today

Positive Study Results Published for KidneyIntelX

January 11, 2022
RNS Number : 1056Y Renalytix PLC 11 January 2022     Renalytix plc ("Renalytix" or the "Company")   Positive Study Results Published for KidneyIntelX TM in Monitoring Patient Response to New Drug Therapy   American Journal of Nephrology   data demonstrates KidneyIntelX successfully monitors patient

Partnership with Singing River for KidneyIntelX

January 10, 2022
RNS Number : 8490X Renalytix PLC 10 January 2022     Renalytix plc ("Renalytix" or the "Company")   Singing River Health System and Renalytix Join Forces to Improve Kidney Health   on the   Mississippi Gulf Coast Seventh KidneyIntelX implementation partnership for Renalytix focused on underserved

Appointment of Jean M. Casner as CHRO

January 7, 2022
RNS Number : 7098X Renalytix PLC 07 January 2022     Renalytix plc ("Renalytix" or the "Company")   Renalytix Appoints Jean M. Casner as Chief Human Resources Officer   NEW YORK, NY and SALT LAKE CITY, UT   January 7, 2022 - Renalytix plc   (NASDAQ: RNLX) (LSE: RENX) today announced that Jean M.

RENX to present at 40th JP Morgan Healthcare Conf.

January 5, 2022
RNS Number : 4318X Renalytix PLC 05 January 2022     Renalytix plc ("Renalytix" or the "Company")   Renalytix to Present at 40 th Annual J.P. Morgan Virtual Healthcare Conference   LONDON and SALT LAKE CITY , January 5, 2022 - Renalytix plc (LSE: RENX) (NASDAQ: RNLX) today announced the Company
Displaying 21 - 30 of 209